Research News and Research

RSS

Mystery of arsenite solved

Scientists have solved an important mystery about why an arsenic compound, called arsenite, can kill us, and yet function as an effective therapeutic agent against disease and infections. According to new research published in the October 2010 issue of Genetics scientists from Johns Hopkins, Baylor and Stanford discovered that arsenite, a common water contaminant in many parts of the world, affects a special protein folding machine in yeast, called TCP, also present in humans.

14 Oct 2010

Experts reach consensus about DBS treatment for Parkinson's disease

Since the late 1990s, deep brain stimulation (DBS) has proven to be a lifeline for some patients suffering from Parkinson's disease, a cruel neurological disorder that can cause lack of control over movement, poor balance and coordination, and rigidity, among other symptoms.

14 Oct 2010

Researchers seek to end disparities in cancer, stroke care

HealthDay/U.S. News & World Report: Research has shown that there is a racial gap in breast cancer care, "with black and Hispanic women less likely to get recommended breast cancer treatments than white patients."

14 Oct 2010

Stony Brook professor receives NIH grant to optimize cardiovascular devices

Danny Bluestein, Ph.D., Professor of Biomedical Engineering at Stony Brook University, has been awarded a five-year, $7.5 million grant by the National Institutes of Health. The award marks the first time a Stony Brook professor has received a Phase II Quantum Grant, given by The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a division of the NIH, to make a profound improvement or quantum leap forward—in health care.

14 Oct 2010

NIH awards grant to Bavarian to advance early research in filoviruses

Bavarian Nordic A/S announced today that the company has received funding from the U.S. National Institutes of Health (NIH) to advance its early research in filoviruses (Ebola and Marburg virus).

14 Oct 2010

Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis

Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.

14 Oct 2010

Stimulating brain's nicotine receptors may eliminate side effects of Alzheimer's drug: Research

A team of neuroscientists has discovered important new information in the search for an effective treatment for Alzheimer's disease, the debilitating neurological disorder that afflicts more than 5.3 million Americans and is the sixth-leading cause of death in the United States. Hey-Kyoung Lee, associate professor in the University of Maryland Department of Biology, and her research team have shown that they may be able to eliminate debilitating side effects caused by a promising Alzheimer's drug by stimulating the brain's nicotine receptors.

14 Oct 2010

State roundup: N.Y.'s retiree health benefits crisis; Colorado referendum

The New York Times: "The cities, counties and authorities of New York have promised more than $200 billion worth of health benefits to their retirees while setting aside almost nothing, putting the public work force on a collision course with the taxpayers who are expected to foot the bill. … The total cost appears in a report to be issued on Wednesday by the Empire Center for New York State Policy, a research organization that studies fiscal policy.

14 Oct 2010

Walking six miles per week preserves memory in old age

New research suggests that walking at least six miles per week may protect brain size and in turn, preserve memory in old age, according to a study published in the October 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Oct 2010

XenoPort to present XP23829 preclinical data at ECTRIMS meeting

XenoPort, Inc. announced today that it will present data on a new preclinical product candidate, XP23829, at the upcoming 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Gothenburg, Sweden, October 13 - 16, 2010.

14 Oct 2010

Children recognise signs of neglect in peers: Survey

Researchers for Action for Children in a survey of over 3,000 eight to 12 year-olds found that 44% of children under 12 have seen other children who were dirty and smelled. Nearly two-thirds of children have seen suspected signs of neglect among their peers in classrooms, playgrounds, neighborhoods and activity clubs.

13 Oct 2010

NHS bonuses under scanner

The NHS bonus scheme is being criticized. The scheme originated in 1948 when the NHS was created. They are available to consultants and are designed to reward excellence in research, teaching and, of course, clinical care.

13 Oct 2010

Taller kids with IVF: Study

A new study has found that children born via IVF are typically taller than those born naturally. Newborn IVF babies created from a fresh embryo transferred back into the mother, also tended to be about 190g lighter than naturally conceived children.

13 Oct 2010

Global project to find biological activity in sea organisms suitable for pharmaceutical products

Researchers at the Faculty of Pharmacy at the University of Helsinki are co-ordinating an extensive project which aims to find biological activity from among organisms in the sea which would be suitable for use as a basis for pharmaceutical products. Interesting compounds isolated from organisms in the sea are chemically modified to be more suitable for medical purposes.

13 Oct 2010

Medicago and PATH partner on development of broad coverage influenza vaccine

Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded $946,000 in funding by U.S.-based PATH pursuant to a research collaboration agreement. Medicago and PATH will work together on a broad coverage influenza vaccine based on Medicago's proprietary plant-based Virus-Like Particle (VLP) technologies for the developing world.

13 Oct 2010

TrovaGene receives patent for diagnosis and monitoring of pathogenic infection

TrovaGene, Inc. a developer of transrenal molecular diagnostics to facilitate personalized medicine, received notice of U.S. Patent 7,803,929 entitled "Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine."

13 Oct 2010

Dr. Nabarro to deliver keynote address at Third McGill Conference on Global Food Security

Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.

13 Oct 2010

Canadian Cancer Society announces 'Feast for the Fight' fundraising event

Torontonians along parts of Yonge Street will have the chance to feel good while enjoying a night on the town with Feast for the Fight, a new fundraising event by the Canadian Cancer Society. Like a meal paired with fine wine, Feast for the Fight matches some of Toronto's finest restaurateurs with the country's leading cancer charity, culminating in a philanthropic dining experience.

13 Oct 2010

Research shows honey bees change their circadian rhythms

Unlike humans, honey bees, when thrown into highly time-altered new societal roles, are able to alter their biological rhythms with alacrity, enabling them to make a successful "quick switch" in their daily routines, according to research carried out at the Hebrew University of Jerusalem.

13 Oct 2010

Nurses can advocate for better healthcare and services for LGBTIQ teenagers

Five American teenagers, all bullied because they were gay, have committed suicide over the past few weeks. The deaths have caused a media storm and raised a critical question: Did the social or healthcare system fail these adolescents? "Absolutely," says Concordia University Professor Deborah Dysart-Gale. "Bullying and such resulting suicides are avoidable. Healthcare workers have tools that can help queer teens - no one needs to die because of their sexual orientation."

13 Oct 2010